To include your compound in the COVID-19 Resource Center, submit it here.

RaQualia, CJ Group in gastrointestinal deal

RaQualia Pharma Inc. (JASDAQ:4579) granted CJ Group (Seoul, South Korea) exclusive rights

Read the full 125 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE